Marcourakis, Tania 
; Bernik, Marcio Antonini; Lotufo Neto, Francisco; Shavitt, Roseli Gedanke; Gorenstein, Clarice
Source: International Clinical Psychopharmacology. Unidades: FCF, FM, ICB
Assunto: TRANSTORNO OBSESSIVO-COMPULSIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCOURAKIS, Tania et al. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment. International Clinical Psychopharmacology, v. 30, n. 1, p. 43-48, 2015Tradução . . Disponível em: https://doi.org/10.1097/YIC.0000000000000050. Acesso em: 18 abr. 2024.APA
Marcourakis, T., Bernik, M. A., Lotufo Neto, F., Shavitt, R. G., & Gorenstein, C. (2015). Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment. International Clinical Psychopharmacology, 30( 1), 43-48. doi:10.1097/YIC.0000000000000050NLM
Marcourakis T, Bernik MA, Lotufo Neto F, Shavitt RG, Gorenstein C. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment [Internet]. International Clinical Psychopharmacology. 2015 ; 30( 1): 43-48.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1097/YIC.0000000000000050Vancouver
Marcourakis T, Bernik MA, Lotufo Neto F, Shavitt RG, Gorenstein C. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment [Internet]. International Clinical Psychopharmacology. 2015 ; 30( 1): 43-48.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1097/YIC.0000000000000050
